Recent Added Health Technologies
- Loxapine inhalation for agitation associated with schizophrenia or bipolar disorder
- Afatinib for advanced and/or metastatic non-small cell lung cancer (NSCLC) with EGFR mutation
- Apixaban for stroke prevention in atrial fibrillation
- Axitinib for advanced and/or metastatic renal cell carcinoma – second line.
- Bevacizumab with trastuzumab and docetaxel for metastatic HER2 positive breast cancer
- Oral calcitonin for osteoarthritis (OA) of the knee in men and postmenopausal women – first line
- Vorapaxar for acute coronary syndrome
- Erlotinib hydrochloride (Tarceva) for advanced non-small cell lung cancer with activating mutations
- OncoVEX GM-CSF for unresectable metastatic melanoma – first and second line treatment
- Taspoglutide for type 2 diabetes mellitus